KeyBanc initiated coverage of RadNet (RDNT) with an Overweight rating and $92 price target
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RDNT:
- RadNet acquires Radiology Regional, terms not disclosed
- RadNet names Mital Patel as COO, announces expanded executive roles
- Oncology Institute appoints Mark Stolper to board of directors
- RadNet’s Strategic Growth and AI Success Justify Buy Rating Despite Concerns
- RadNet short report points already known and disclosed, says Raymond James